3-aminobenzamide has been researched along with Granulocytic Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mi, Y | 1 |
| Thomas, SD | 1 |
| Xu, X | 1 |
| Casson, LK | 1 |
| Miller, DM | 1 |
| Bates, PJ | 1 |
| Selle, A | 1 |
| Ullrich, O | 1 |
| Harnacke, K | 1 |
| Hass, R | 1 |
| Palomba, L | 1 |
| Sestili, P | 1 |
| Cattabeni, F | 1 |
| Azzi, A | 1 |
| Cantoni, O | 1 |
3 other studies available for 3-aminobenzamide and Granulocytic Leukemia
| Article | Year |
|---|---|
Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin.
Topics: Apoptosis; Benzamides; Camptothecin; Enzyme Inhibitors; Humans; In Situ Nick-End Labeling; Leukemia, | 2003 |
Retrodifferentiation and rejuvenation of senescent monocytic cells requires PARP-1.
Topics: Apoptosis; Benzamides; Cell Differentiation; Cell Proliferation; Cellular Senescence; DNA, Antisense | 2007 |
Prevention of necrosis and activation of apoptosis in oxidatively injured human myeloid leukemia U937 cells.
Topics: Apoptosis; Benzamides; Cell Line; Culture Media; DNA, Neoplasm; Enzyme Inhibitors; Humans; Hydrogen | 1996 |